Rare diseases
Investigational molecules
Locations
Back to the Netherlands73 clinical trials in Deventer, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
The NetherlandsThe NetherlandsStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
The NetherlandsStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
The NetherlandsRituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia
The NetherlandsStudy of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
The NetherlandsA study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations
The NetherlandsTesting a Drug Combination with Fluorouracil, Irinotecan, Oxaliplatin, and Folinic Acid Plus Radiation Therapy for Patients with Advanced Rectal Cancer
The NetherlandsA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
The NetherlandsStudy of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
The NetherlandsEvaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression
The NetherlandsStudy on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on heart failure prevention and treatment of cardiovascular diseases. Studies evaluate new therapeutic approaches for reducing cardiac events and improving patient outcomes.
Multiple studies examining novel medications and combination therapies for cardiovascular risk reduction.
Comprehensive research into various cancer types, including urothelial cancer, colorectal liver metastases, and esophageal squamous cell carcinoma.
Investigating innovative treatment approaches and combination therapies for various cancer types.
Advanced research in severe asthma treatment and respiratory tract infections. Studies focus on novel therapeutic approaches and treatment optimization.
Evaluating new treatment protocols and comparing effectiveness of different therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
